Company Information & Drug Savings for Novo Nordisk Inc. Medications
Novo Nordisk is a Danish pharmaceutical company and global leader in diabetes care, obesity treatment, and rare blood disorders. Key products include Ozempic and Wegovy (semaglutide) for type 2 diabetes and weight loss, Saxenda (liraglutide) for obesity, Tresiba and Levemir insulins, and NovoSeven for hemophilia. Novo Nordisk’s GLP-1 receptor agonists have transformed diabetes management and are revolutionizing obesity treatment worldwide.
How to Contact Novo Nordisk Inc.
Phone
1-800-727-6500Browse Medications Manufactured by Novo Nordisk Inc.
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
